Stuart L. Goldberg, MD, on Approaching Biomarker Testing with Patients

Article

The expert spoke about the best way for physicians to discuss biomarker testing with their patients to ensure that they have an understanding and can make the right decisions for their treatment.

Stuart L. Goldberg, MD, from Hackensack University Medical Center, discussed how health care providers should approach the topic of biomarker testing with their patients so that they are better informed and can make proper treatment decisions in an interview with CancerNetwork®

Transcription:

Well, talking to our patients about genomics is no different than talking to them about their underlying cancer. We need to spend the time, we need to think about what the patient’s education level is, so that we communicate in a way that they can understand. We don’t want to give them information overload, especially during a critical time when they’re just diagnosed, and they’re scared about it. But at the same time, we can’t hold back information that’s important to making a decision. 

 

I think that if we think about the patient, you know, if it were our loved one, what’s the information that we would want them to have to make the right decisions and to understand what we’re doing. And we don’t have to give it all in the first visit. We can, you know, we’re going to have our long-term relationship with these patients. We want to make sure that we spoon that information out over time as they learn more about their disease. So, communicating genomics is no different than communicating about cancer therapies, which we’ve done for years. It’s just now a new part of what we have to talk about. 

Related Videos
Prophylactic cranial irradiation may not be worthwhile for treating patients with extensive-stage small cell lung cancer based on conflicting data, according to Gregory Peter Kalemkerian, MD.
FDA-approved immunotherapy options such as atezolizumab and durvalumab have produced substantial benefits in certain groups of patients with extensive-stage small cell lung cancer, says Gregory Peter Kalemkerian, MD.
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey K. Anders, MD, an expert on breast cancer
A panel of 4 experts on breast cancer seated at a long table
A panel of 4 experts on breast cancer seated at a long table
Related Content